Plasma rich in growth factors — Competitive Intelligence Brief

Plasma rich in growth factors (Plasma rich in growth factors) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Autologous cell/tissue therapy. Area: Regenerative Medicine / Orthopedics.

phase 3 Autologous cell/tissue therapy Regenerative Medicine / Orthopedics Biologic

Target snapshot

Plasma rich in growth factors (Plasma rich in growth factors) — Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias. Plasma rich in growth factors (PRGF) delivers concentrated autologous growth factors and cytokines to promote tissue repair and regeneration.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Plasma rich in growth factors TARGET	Plasma rich in growth factors	Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias	phase 3	Autologous cell/tissue therapy
PRGF/ATV	PRGF/ATV	Ain Shams University	marketed	Autologous cell/tissue therapy with growth factor concentrate
Platelet Rich Fibrin Matrix kit	Platelet Rich Fibrin Matrix kit	KLE Society's Institute of Dental Sciences	phase 3	Autologous cell/tissue therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Autologous cell/tissue therapy class)

1. Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias · 1 drug in this class
2. KLE Society's Institute of Dental Sciences · 1 drug in this class